A.P. Pharma, Inc.
A.P. Pharma Reports Third Quarter Financial Results
Published in Surgery Litigation and Law Weekly, November 30th, 2007
A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical company, reported financial results for its third quarter ended September 30, 2007. -0- *T Highlights Operational: -- APF530 (Prevention of CINV) -- Patient enrollment continues towards completion by Spring 2008 -- Trial results targeted for Q3 2008 -- NDA filing planned for late 2008 -- APF112 (Post-surgical pain relief) -- Preclinical work proceeding currently -- Anticipate initiation of Phase 2b trial first half 2008 -- APF580 (Intense pain relief) -- Progressing towards IND submission -- Anticipate initiation of Phase 1 trial first half 2008 Financial: -- Cash, cash equivalents and marketable securities $39.8 million...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly
More Articles from Surgery Litigation and Law Weekly
- Arthroscopy
Researchers from Loyola Marymount University report details of new studies and findings in the area of arthroscopy - Ophthalmology
Escalon(R) Announces Promotion of Industry Veteran Barry Durante to President of Sonomed, Inc. - Patents
OraSure Technologies and Schering-Plough to Settle Patent Infringement Litigation - Abdominal Aortic Aneurysm
New abdominal aortic aneurysm research has been reported by scientists at Mayo Clinic - Abdominal Aortic Aneurysm
Researchers at University of London, Imperial College target abdominal aortic aneurysm - Abdominal Pain
Antegrade bowel intussusception can cause recurrent, chronic postoperative intestinal obstruction - More from this issue of Surgery Litigation and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
